Relapsing Multiple Sclerosis
Relapsing Multiple Sclerosis (RMS) is a form of multiple sclerosis characterized by episodes of neurological symptoms that can improve or resolve between attacks.
Multiple Sclerosis: CD19-targeted CAR T Cell Therapy
We are testing a new CAR T cell treatment for people with relapsing or progressive multiple sclerosis. The goal is to see if it can improve symptoms and overall health.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Progressive Multiple Sclerosis
Progressive Multiple Sclerosis (PMS) is a type of multiple sclerosis that leads to a gradual worsening of symptoms over time, without distinct relapses.
Myasthenia Gravis
Myasthenia Gravis (MG) is an autoimmune disorder that causes weakness in the skeletal muscles, leading to difficulties in movement and control.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitair Ziekenhuis Gent
Neurology
Ledeberg, Belgium
Antwerp University Hospital
Neurology
Wilrijk, Belgium
Centre Hospitalier Universitaire De Lille
Service Maladies du sang
Loos, France
Sponsor: Celgene Corp.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.